Clinical Trials Search Results

Showing 1-10 of 16

Sorted By:

  • Breast Cancer - DFCI 06-169

    The Young Women's Breast Cancer Study

  • Breast Cancer - SWOG 1007

    For patients with 1-3 positive nodes, hormone receptor positive and HER2 negative breast cancer with recurrence score (RS) of 25 or less.


    This registry is for individuaols who are newly diagnosed with MDS or AML. A bone marrow biposy must be done within 60 days of joining.

  • Endomax

    •Laboratory testing while in hospital •30 day clinic visit with laboratory testing •Telephone follow-up at 1 year

  • Exscel

    •Clinic visits during screening, randomization, week 1 and month 2 & every 6 months •Laboratory assessments at visits •participation is between 3 and 5 years

  • Multiple Myeloma Connect MM

    To help establish which treatments are effective in the treatment of Multiple Myeloma. This is a data registry and not a clinical trial that requires specific treatment regimes.

  • Multiple Myeloma DFCI 08-273

    Phase II trial of combination Plerixafor (AMD3100), Bortezomib & Dexamethasone in relapsed or relapsed/refractory multiple myeloma.

  • Multiple Myeloma DFCI 10-106

    Comparing conventional dose treatment using lenalidomide, bortezomib and dexamethasone (RVD) to high dose treatment with peripheral stem cell transplant.

  • Multiple Myeloma DFCI 12-498

    A Phase II study of modified Lenalidomide, Bortezomib and Dexamethasone for Transplant Ineligible patients with newly diagnosed multiple myeloma.

  • Observational Cohort Study - DFCI 03-385

    Women > 65 years who are candidates for surgery

Page of 2, showing trials 1-10 of 16

Contact Us

Cape Cod Hospital
27 Park Street
Hyannis MA 02601
Phone: 508-771-1800

Falmouth Hospital
100 Ter Heun Drive
Falmouth, MA 02540
Phone: 508-548-5300